Stabilitech awarded US contract to develop stable biodefence vaccines
This article was originally published in Scrip
Executive Summary
Stabilitech, a privately held UK company developing technology to stabilise vaccines and other biological products against heat and freeze damage, has signed a contract with the Defense Threat Reduction Agency (DTRA) of the US Department of Defense.